DK171043B1 - 7-beta-(carboxyalkenoylamino)-3-cephem-4-carboxylsyrederivater - Google Patents

7-beta-(carboxyalkenoylamino)-3-cephem-4-carboxylsyrederivater Download PDF

Info

Publication number
DK171043B1
DK171043B1 DK474584A DK474584A DK171043B1 DK 171043 B1 DK171043 B1 DK 171043B1 DK 474584 A DK474584 A DK 474584A DK 474584 A DK474584 A DK 474584A DK 171043 B1 DK171043 B1 DK 171043B1
Authority
DK
Denmark
Prior art keywords
carboxylic acid
mixture
cephem
acid
carboxy
Prior art date
Application number
DK474584A
Other languages
Danish (da)
English (en)
Other versions
DK474584D0 (da
DK474584A (da
Inventor
Yoshio Hamashima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58186601A external-priority patent/JPS6078987A/ja
Priority claimed from JP59018563A external-priority patent/JPS60163884A/ja
Priority claimed from JP59100890A external-priority patent/JPH0780892B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK474584D0 publication Critical patent/DK474584D0/da
Publication of DK474584A publication Critical patent/DK474584A/da
Application granted granted Critical
Publication of DK171043B1 publication Critical patent/DK171043B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
DK474584A 1983-10-04 1984-10-03 7-beta-(carboxyalkenoylamino)-3-cephem-4-carboxylsyrederivater DK171043B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP18660183 1983-10-04
JP58186601A JPS6078987A (ja) 1983-10-04 1983-10-04 アクリルアミドセフアロスポリン類
JP59018563A JPS60163884A (ja) 1984-02-03 1984-02-03 カルボキシアルケンアミドセフアロスポリン
JP1856384 1984-02-03
JP59100890A JPH0780892B2 (ja) 1984-05-18 1984-05-18 カルボキシアルケンアミドセフアロスポリン
JP10089084 1984-05-18

Publications (3)

Publication Number Publication Date
DK474584D0 DK474584D0 (da) 1984-10-03
DK474584A DK474584A (da) 1985-04-05
DK171043B1 true DK171043B1 (da) 1996-04-29

Family

ID=27282263

Family Applications (1)

Application Number Title Priority Date Filing Date
DK474584A DK171043B1 (da) 1983-10-04 1984-10-03 7-beta-(carboxyalkenoylamino)-3-cephem-4-carboxylsyrederivater

Country Status (22)

Country Link
US (3) US4634697A (fi)
EP (1) EP0136721B1 (fi)
KR (2) KR880002376B1 (fi)
AR (1) AR242392A1 (fi)
AT (1) ATE99311T1 (fi)
AU (2) AU575854B2 (fi)
CA (2) CA1238910A (fi)
DE (2) DE3486259T2 (fi)
DK (1) DK171043B1 (fi)
ES (3) ES8604602A1 (fi)
FI (1) FI82057C (fi)
GB (3) GB2154580B (fi)
GR (1) GR80544B (fi)
HU (1) HU193298B (fi)
IE (1) IE57744B1 (fi)
IL (3) IL84653A (fi)
MX (1) MX174328B (fi)
NL (1) NL940013I2 (fi)
NO (2) NO173238C (fi)
NZ (2) NZ209634A (fi)
PH (2) PH20223A (fi)
PT (1) PT79287A (fi)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
JP2501785B2 (ja) * 1984-07-09 1996-05-29 明治製菓株式会社 新規セフアロスポリン系化合物
JPS6124580A (ja) * 1984-07-12 1986-02-03 Shionogi & Co Ltd アミノチアゾリルグルタル酸誘導体の製造方法
JPS6153272A (ja) * 1984-08-24 1986-03-17 Shionogi & Co Ltd グルタル酸誘導体の製法
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters
EP0202046B1 (en) 1985-04-30 1991-01-30 Eli Lilly And Company 7-substituted bicyclic pyrazolidinones
US4731362A (en) * 1985-08-05 1988-03-15 Shionogi & Co., Ltd. Alkylcarbamoyloxymethylcephem compounds
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
AT396652B (de) * 1986-07-02 1993-11-25 Shionogi & Co Verfahren zur herstellung von hartgelatinekapsel-zusammensetzungen
DE3745094B4 (de) * 1986-07-02 2004-12-30 Shionogi & Co., Ltd. Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung
US5017380A (en) * 1986-07-02 1991-05-21 Shionogi & Co., Ltd. Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
US5242913A (en) * 1987-03-11 1993-09-07 Pfizer Inc. Substituted 3-cephem compounds as antibacterial agents
WO1993013108A1 (en) * 1987-03-11 1993-07-08 Susumu Nakanishi Substituted 3-cephem compounds as antibacterial agents
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
US5245027A (en) * 1989-11-21 1993-09-14 Bristol-Myers Squibb Company 3-fluorosulfonyloxyceph-3-em compounds
US5612048A (en) * 1994-11-22 1997-03-18 Amvac Chemical Corporation Stabilized moisture-sensitive pesticide composition and method of making
US5571910A (en) * 1994-12-09 1996-11-05 Schering Corporation Process for the preparation of intermediates useful in the synthesis of cephalosporins
JPH101482A (ja) * 1996-06-13 1998-01-06 Otsuka Chem Co Ltd 3−ノルセフェム化合物の製造法
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US8225458B1 (en) 2001-07-13 2012-07-24 Hoffberg Steven M Intelligent door restraint
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
US20050152852A1 (en) * 2002-05-27 2005-07-14 Morinaga & Co., Ltd. Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005009365A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004264939A1 (en) * 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS
AU2005269981A1 (en) * 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008082488A1 (en) * 2006-12-22 2008-07-10 Schering Corporation 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
RU2009127855A (ru) 2006-12-22 2011-01-27 Шеринг Корпорейшн (US) 4,5 циклоаннелированные производные индола для лечения или предотвращения вируса гепатита с (hcv) и родственных вирусных инфекций
CN101611025A (zh) 2006-12-22 2009-12-23 先灵公司 5,6-环化的吲哚衍生物及其使用方法
KR20100067652A (ko) 2007-08-29 2010-06-21 쉐링 코포레이션 치환된 인돌 유도체 및 이의 사용방법
CN101842374A (zh) * 2007-08-29 2010-09-22 先灵公司 用于治疗病毒感染的2,3-取代的氮杂吲哚衍生物
CN101842353A (zh) * 2007-08-29 2010-09-22 先灵公司 用于治疗病毒感染的2,3-取代的吲哚衍生物
US8377928B2 (en) * 2007-11-16 2013-02-19 Merck Sharp & Dohme Corp. 3-aminosulfonyl substituted indole derivatives and methods of use thereof
CA2705586A1 (en) * 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
US8901139B2 (en) * 2008-06-13 2014-12-02 Merck Sharp & Dohme Corp. Tricyclic indole derivatives and methods of use thereof
CA2734488A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
AR072939A1 (es) 2008-08-20 2010-09-29 Schering Corp Derivados de piridina y pirimidina sustituidas con etenilo y su uso en el tratamiento de infecciones virales
CA2734486A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2331511A1 (en) 2008-08-20 2011-06-15 Schering Corporation Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2435424B1 (en) 2009-05-29 2015-01-21 Merck Sharp & Dohme Corp. Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
WO2011066241A1 (en) 2009-11-25 2011-06-03 Schering Corporation Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
CA2785488A1 (en) 2009-12-22 2011-07-21 Merck Sharp & Dohme Corp. Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
US9433621B2 (en) 2010-02-18 2016-09-06 Merck Sharp & Dohme Corp. Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
PE20130062A1 (es) 2010-03-09 2013-02-28 Merck Sharp & Dohme Compuestos de sililo triciclicos fusionados para el tratamiento de enfermedades virales
CN101824004B (zh) * 2010-04-30 2012-02-22 黄山市歙县宏辉化工有限公司 一种头孢布烯侧链的合成工艺
WO2011139253A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
WO2012018534A2 (en) 2010-07-26 2012-02-09 Schering Corporation Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
AU2011314168A1 (en) 2010-09-29 2013-04-04 Merck Sharp & Dohme Corp. Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
US9156872B2 (en) 2011-04-13 2015-10-13 Merck Sharp & Dohme Corp. 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
PE20140522A1 (es) 2011-04-13 2014-05-03 Merck Sharp & Dohme Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
WO2013109225A1 (en) 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical tablet formulations comprising ceftibuten
EP2833874A1 (en) 2012-04-04 2015-02-11 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
WO2015065817A1 (en) 2013-10-30 2015-05-07 Merck Sharp & Dohme Corp. Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB149039A (en) * 1919-04-30 1920-07-30 Lawrence Ennis Improvements in or relating to steel framed cottages
GB966131A (en) * 1959-04-07 1964-08-06 Union Carbide Corp Process for the preparation of organic compounds
US3994888A (en) * 1973-06-18 1976-11-30 Eli Lilly And Company Cephalosporin cleavage process
GB1497039A (en) * 1973-12-05 1978-01-05 Glaxo Lab Ltd Penicillins and cephalosporins
US4263212A (en) * 1979-02-28 1981-04-21 Rikagaku Kenkyusho Process for preparation of substituted olefins
GB2076801A (en) * 1980-04-14 1981-12-09 Erba Farmitalia alpha , beta -Disubstituted Acrylamido Cephalosporins
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3145727A1 (de) * 1981-11-19 1983-05-26 Bayer Ag, 5090 Leverkusen Zwischenprodukte, verfahren zu deren herstellung und verfahren zur herstellung von cephalosporinen
CA1201431A (en) * 1981-12-17 1986-03-04 Daiei Tunemoto .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
DE3224866A1 (de) * 1982-07-02 1984-01-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3300593A1 (de) * 1983-01-11 1984-07-12 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins

Also Published As

Publication number Publication date
US4748170A (en) 1988-05-31
AU3330084A (en) 1985-05-09
MX174328B (es) 1994-05-09
HU193298B (en) 1987-09-28
AR242392A1 (es) 1993-03-31
EP0136721B1 (en) 1993-12-29
CA1238910A (en) 1988-07-05
DK474584D0 (da) 1984-10-03
AU1619488A (en) 1988-08-11
FI82057B (fi) 1990-09-28
GB2198727B (en) 1988-11-16
FI843871A0 (fi) 1984-10-02
ES547300A0 (es) 1986-11-16
NO176567B (no) 1995-01-16
KR850002989A (ko) 1985-05-28
NO843956L (no) 1985-04-09
NZ209634A (en) 1988-07-28
GB8726623D0 (en) 1987-12-16
ATE99311T1 (de) 1994-01-15
US4912224A (en) 1990-03-27
GB2198727A (en) 1988-06-22
CA1272713C (fi) 1990-08-14
DK474584A (da) 1985-04-05
GR80544B (en) 1985-02-05
ES547301A0 (es) 1986-03-16
EP0136721A3 (en) 1986-01-22
GB2154580B (en) 1988-08-17
FI82057C (fi) 1991-01-10
ES8605278A1 (es) 1986-03-16
PT79287A (en) 1984-11-01
KR880002376B1 (ko) 1988-11-03
ES536502A0 (es) 1986-02-01
NO173238B (no) 1993-08-09
FI843871L (fi) 1985-04-05
KR880002684B1 (ko) 1988-12-20
NL940013I1 (nl) 1994-08-16
ES8700222A1 (es) 1986-11-16
GB2190914B (en) 1988-08-17
EP0136721A2 (en) 1985-04-10
IE57744B1 (en) 1993-03-24
NO853806L (no) 1985-04-09
IL84653A0 (en) 1988-04-29
CA1272713A (en) 1990-08-14
NZ218741A (en) 1988-07-28
IE842524L (en) 1985-04-04
AU575854B2 (en) 1988-08-11
GB8424923D0 (en) 1984-11-07
IL73159A (en) 1990-08-31
NO173238C (no) 1993-11-17
NL940013I2 (nl) 1999-06-01
DE136721T1 (de) 1985-08-29
HUT36129A (en) 1985-08-28
GB2154580A (en) 1985-09-11
DE3486259T2 (de) 1994-07-21
IL73159A0 (en) 1985-01-31
GB8700123D0 (en) 1987-02-11
GB2190914A (en) 1987-12-02
AU601842B2 (en) 1990-09-20
PH20223A (en) 1986-10-23
NO176567C (no) 1995-04-26
DE3486259D1 (de) 1994-02-10
US4634697A (en) 1987-01-06
PH21766A (en) 1988-02-18
ES8604602A1 (es) 1986-02-01
IL84653A (en) 1990-08-31

Similar Documents

Publication Publication Date Title
DK171043B1 (da) 7-beta-(carboxyalkenoylamino)-3-cephem-4-carboxylsyrederivater
US4520022A (en) Substituted vinyl cephalosporins
KR870002166B1 (ko) 항박테리아 화합물의 제조방법
US4731362A (en) Alkylcarbamoyloxymethylcephem compounds
US4731361A (en) Alkeneamidocephalosporin esters
EP0265185A2 (en) Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
CS258142B2 (en) Method of 3-(subst.)propenylaminothiazolyl-cephaelosporane acids' and their esters' production
KR870002181B1 (ko) 세팔로스포린의 제조방법
SU1274625A3 (ru) Способ получени цефалоспорина или его солей
JP2001506607A (ja) セファロスポリン誘導体
CS248749B2 (en) Production method of the 6-(subst.)hydroxymethylpenicilan acids
JP3238209B2 (ja) チオメチルチオカルバセファロスポリン誘導体
JPH068300B2 (ja) 新規セフアロスポリン誘導体
JP2567799B2 (ja) カルボキシアルケン酸及びその誘導体
EP0481441B1 (en) Novel cephem compounds, their preparation processes and antibacterial agents
KR0157589B1 (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법
FI88042B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporansyraderivat
EP1077981A1 (en) Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same
JPS61130293A (ja) ふつ素化アルキルセフアロスポリン類
JPS60163884A (ja) カルボキシアルケンアミドセフアロスポリン
JPH0532671A (ja) 新規なセフエム化合物、その製造法及び抗菌剤
CS268513B2 (en) Method of 7 beta-(carboxyalkanolamino)-3-cefem-carboxyl acids production
JPH01268692A (ja) 3−(1−置換ピリジニウム−4−イル)チオメチルセファロスポリン誘導体
JPH0645629B2 (ja) 新規セフアロスポリン誘導体
JPS61122289A (ja) 新規セフアロスポリン化合物,該化合物の製造法および該化合物を含有する医薬

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1996 00014, 960724

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1996 00014, 960724, EXPIRES: 20070303

PUP Patent expired